莲黄汤治疗母儿ABO血型不合的临床疗效观察  

Effects of Lianhuang Decoction in Treating Fetomaternal ABO Blood Group Incompatibility

作　　者：蔡珠华[1] 陈颖异[1] 曾珏[1] 钱定良[1] 谢丽华[1] 周淑春[1] 

机构地区：[1]温州医学院附属第三医院瑞安市人民医院,浙江325200

出　　处：《中国中西医结合杂志》2009年第2期156-158,共3页Chinese Journal of Integrated Traditional and Western Medicine

基　　金：浙江省瑞安市科技局立项课题(No.20061068)

摘　　要：目的观察莲黄汤治疗母儿ABO血型不合的临床疗效。方法对60例母儿ABO血型不合的孕妇随机分为两组,A组采用莲黄汤加减治疗,B组采用西医治疗,随访疗效。结果两组抗体效价均有不同程度的下降,A组有效率为90.0%,B组有效率为56.7%。A组新生儿平均脐血胆红素低于B组,差异有统计学意义(P<0.01)。两组新生儿5 min Apgar评分、体重及脐血血红蛋白含量差异均无统计学意义(P>0.05)。结论莲黄汤治疗母儿ABO血型不合有较好的疗效,能有效降低其血清抗体效价,预防产后新生儿ABO溶血病的发生。Objective To investigate the clinical curative effect of Lianhuang Decoction(LHD) in treating fetomaternal ABO blood group incompatibility(FM-ABOI).MethodsSixty pregnancy women diagnosed as FM-ABOI were randomly assigned to two groups,Group A treated with LHD and Group B treated with Western medicine.The therapeutic efficacy in the two groups was observed.ResultsThe antibody titer decreased after treatment in both groups to different extent;the effective rate was 90.0% in Group A and 56.7% in Group B.The bi...

关 键 词：母儿ABO血型不合 莲黄汤 血清抗体效价 

分 类 号：R272[医药卫生—中医儿科学]